Greenback's reign isn't over, but cracks are showing
THE US dollar remains the undisputed heavyweight in the global financial system: Central banks hoard it; global trade is priced on it; and financial markets are built around it. However, that dominance, long taken for granted, is being tested.
From shifting geopolitical alliances to evolving investment behaviour, the forces nibbling at the dollar's dominance are multiplying. There is no clear successor so far, but cracks are forming in its foundation.
For decades, the dollar has anchored the global monetary system, thanks not only to the US' economic power, but also to its deep, liquid capital markets and perceived political stability. However, these advantages are no longer absolute. International investors, once content to be heavily exposed to US assets, are starting to hedge their bets more actively.
Combine that with rising US debt, policy unpredictability and a trend toward regional currency use in trade, and the case for a weaker dollar, at least in the near term, starts to build.
Dollar's gradually diminishing role
Let us be clear: there is still no real alternative to the dollar. The euro lacks a true fiscal union and deep bond markets. The yuan remains constrained by capital controls. Even with all the talk about multipolar currencies, the dollar remains deeply embedded in how the world trades, borrows and invests.
The dollar currently makes up 58 per cent of global foreign exchange reserves, more than 80 per cent of global FX turnover and a third of global debt is issued in dollars. These are not numbers that shift quickly. Two decades ago, the dollar's reserve share was closer to 70 per cent. Central banks have steadily diversified – into the euro, yen, sterling, and the 'others' category that includes the Australian dollar, Canadian dollar and Swiss franc. Growing geopolitical tensions and trade fragmentation are only accelerating that shift.
BT in your inbox
Start and end each day with the latest news stories and analyses delivered straight to your inbox.
Sign Up
Sign Up
Trade fragmentation chips away at dollar dominance
The dollar still dominates trade between advanced and emerging economies (EM). But trade between EMs is increasingly bypassing the dollar, with more transactions being settled in local currencies or alternatives.
As at 2022, about three quarters of global trade involved advanced economies, and only a quarter of it was EM to EM or EM to China trade. That smaller slice in trade among EMs is where de-dollarisation is gaining ground. It's not enough to unseat the greenback, but it is reshaping parts of the global economy.
Structural risks from within
The bigger risks to the dollar may come from within. The US federal debt is projected to hit 99 per cent of GDP in 2024 and 118 per cent within a decade, according to the US Congressional Budget Office. This raises concerns about the long-term appeal of US government bonds (Treasuries) as the world's preferred safe asset.
Foreign ownership of Treasuries is already slipping. For years, overseas investors, especially official institutions such as central banks, held large portions of US debt. However, with slower reserve accumulation and greater diversification, foreign holdings of Treasuries and corporate bonds have fallen to about 30 per cent of outstanding amounts.
There are no signs of a broad sell-off, but the US may have to offer higher yields to keep attracting global capital as issuance continues to rise.
Hedging FX risks increasingly important
Beyond central banks and trade, a quiet shift is happening among institutional investors. Foreign investors have accumulated US$56.6 trillion in US financial assets, up from just US$2.2 trillion in 1990. That includes US$16.5 trillion in equities and another US$14.5 trillion in debt securities, with foreign direct investment accounting for a further US$16.5 trillion.
For many years, many investors – pension funds, insurance companies, sovereign wealth funds – did not hedge their dollar exposure aggressively. The dollar's historical tendency to rise in times of stress made it a natural portfolio hedge. This so-called 'USD smile' worked well for years, but it is fading.
Treasuries and the dollar have become less reliable during market stress. That has made the cost of being unhedged far more painful. As a result, we are seeing early signs of increased FX hedging activity. If this continues, it could create sustained downward pressure on the dollar through active USD selling.
Gold: diversification in uncertain times
If there is a winner from the de-dollarisation push, it is gold. Central banks, especially those in EMs, have ramped up gold purchases. The People's Bank of China, for instance, resumed gold buying in 2022 after a three-year pause.
The World Gold Council said net central bank gold purchases reached 1,045 metric tonnes in 2024. Gold now accounts for an estimated 14 per cent of global reserves, up from 8.3 per cent in 2018. Part hedge, part symbol, the appeal of the yellow metal is clear in a world of rising inflation, geopolitical friction and currency uncertainty.
What this means for portfolios
In the near term, these forces point to a softer dollar, especially if FX hedging continues to increase. Over time, the dollar is unlikely to lose its primacy, but its share in global reserves, debt markets and transactions may continue to gradually erode. Investors, policymakers and institutions would be wise to plan for a world where the dollar's leadership becomes more contested.
It is important for global investors to distinguish between cyclical and structural dollar weakness. Cyclical weakness, driven by interest rate differentials, relative US equity market underperformance or mean reversion in terms of valuations, calls for tactical repositioning away from the dollar. But structural weakness, rooted in lasting shifts in global trade, reserve composition and capital flows, would require rethinking strategic asset allocation.
For now, tactical allocation shifts would involve increasing exposure to non-US equities and local-currency bonds, or adding to gold on dips – not just as a short-term hedge, but also as a long-term diversifier. In structural allocations, the dollar remains a foundation currency, but portfolios will likely need to be tweaked in the coming years to reflect the global rebalancing of economic, trade and geopolitical shifts.
The writer is head of asset allocation at Standard Chartered Bank's wealth solutions chief investment office
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Business Times
2 hours ago
- Business Times
Asia healthcare assets risk overvaluation as private investors scoop them up
[SINGAPORE] As private equity (PE) investors pour money into Asian healthcare, some observers are concerned that this sector could soon overheat. Some recent deals this year include KKR's US$400 million purchase of a 54 per cent stake in India's Healthcare Global Enterprises in February. In Singapore, another American PE firm TPG took Catalist-listed nursing operator Econ Healthcare private in a deal worth nearly S$88 million. When the proposed transaction was announced in February, the offer price represented a 20 per cent premium to Econ's last traded share price on Jan 14. 'We are not the only ones to see the opportunity of healthcare in Asia, and, as a consequence, valuations can be high,' Abrar Mir, co-founder and managing partner of healthcare-focused PE firm Quadria Capital, told The Business Times. Other factors driving investors to the healthcare sector – perceived as defensive, and so able to withstand the ups and downs of economic cycles – is the ongoing macroeconomic uncertainty and volatility in global financial markets. This is particularly so in Asia, where investors have been diversifying away from China in the last few years, to avoid being caught in the cross hairs of the nation's tensions with the United States. As PE firms and their investors focus on acquiring companies independent of China, more deals have been transacted in Japan, South Korea and India, where the demand for healthcare and related services is strong and largely unaffected by tariffs. 'Japan has always been a stable healthcare market, and particularly because of (its) demographics and medical needs,' said David Braga Malta, thematic health principal at Pictet Alternative Advisors, to BT. 'We saw some of the mid-sized Japanese pharma companies being very acquisitive in the recent months and years... And of course, we saw the boom in the IPO (initial public offering) markets in India last year.' BT in your inbox Start and end each day with the latest news stories and analyses delivered straight to your inbox. Sign Up Sign Up Asia's appeal even drew European PE investors to buy South Korean assets for the first time in 2024, he added. Last September, France's Archimed spent US$742 million buying Jeisys Medical, a South Korean developer of aesthetic medicine devices. Like shopping in Louis Vuitton 'One of the key things that I always say to my investors is that... investing in healthcare in Asia is like shopping in Louis Vuitton. So, as an investor, we have to navigate that, be careful not to overpay,' said Quadria Capital's Mir. According to a Bain & Co report, global PE deal value in the sector surged last year to an estimated US$115 billion – the second highest on record. Bain added that PE firms continue to invest in healthcare in the Asia-Pacific, where deal values have been steadily rising since 2016. Industry participants named India as the country attracting the most number of healthcare PE investors. An ageing population, rising incidence of chronic disease and growing awareness of preventive care, combined with the opening up of its insurance market to foreign investment, are making India stand out. Bain estimated that the country made up 26 per cent of the 62 deals transacted in the Asia-Pacific last year. PwC said its health industries practice in India hit a double-digit compound annual growth rate in the past few years as well. But Ling Tok Hong, deals and private equity leader at PwC, cautioned that 'this continued focus on the India market could make it more susceptible to overvaluation if investors are not cautious'. South-east Asia's healthcare sector is also attracting PE investors, leading to 'unprecedented valuations' of Ebitda multiples in their 20s, noted Ling. He was referring to earnings before interest, taxes, depreciation and amortisation. Room for growth; returns still strong Despite the rising valuations in Asia's healthcare sector, market participants point out that there is still room for growth, a key factor backing the higher valuations in the first place. The sector offers attractive long-term growth prospects as the supply of quality healthcare assets in the region is not growing quickly enough to meet demand. In markets such as South-east Asia, 'the number of large, institutionally ready platforms is still limited. This scarcity has helped sustain high entry multiples in recent years', said Alex Boulton, partner and Asia-Pacific lead for healthcare and life sciences private equity at Bain. He pointed out that South-east Asia's healthcare sector relies heavily on private players. For instance, the private sector accounts for roughly half of all hospital beds in Indonesia and the Philippines. 'That structural dynamic creates an enduring role for private capital in expanding and upgrading healthcare infrastructure.' Market participants emphasise that Asian healthcare is not in bubble territory. Boulton pointed out that even with rising valuations, healthcare PE in Asia is still delivering strong returns. Bain's analysis shows that from 2018 to 2023, the median multiple on invested capital (MOIC) for exited healthcare deals in the region was approximately 2.6 – meaning that a US$1 million investment generated a return of US$2.6 million. This compares with the global median MOIC of around two. 'That speaks to the sector's ability to compound value through growth and operational improvement, even in a more expensive entry environment,' noted Boulton. That said, while returns are likely to remain strong in the future, the median MOIC may not be sustained at these levels, he added. Thus, market players said, investors will need to have a clear plan to create meaningful impact and value over the life of their investments.

Straits Times
5 hours ago
- Straits Times
Canada to announce new security and defence investment plan, Globe and Mail reports
FILE PHOTO: Canada's Prime Minister Mark Carney speaks during Question Period in the House of Commons on Parliament Hill in Ottawa, Ontario, Canada May 28, 2025. REUTERS/Blair Gable/File Photo Canada to announce new security and defence investment plan, Globe and Mail reports Canadian Prime Minister Mark Carney will unveil a new security and defence investment plan on Monday that would enable Canada to meet NATO's 2% military spending target this fiscal year, the Globe and Mail reported, citing two senior government sources. The spending increase, worth billions of dollars, will allow Canada to meet NATO's 2% target in the fiscal year ending next March and exceed it in future years, the report said. NATO's current defence spending goal of at least 2% of GDP is met by 22 of its 32 members. Canada was near the bottom of the list in 2024, according to estimates published by the alliance. The plan will include higher pay for members of the Canadian Armed Forces, new aircraft, armed vehicles, ammunition, new drones and more sensors to monitor the sea floor and the Arctic, the Globe and Mail said. Reuters could not immediately confirm the report. The Prime Minister's Office did not immediately respond to a request for comment outside regular business hours. The spending announcement would come days before a June 24-25 summit of NATO leaders. Reuters reported last month that NATO chief Mark Rutte had proposed alliance members should boost defence spending to 3.5% of GDP and commit a further 1.5% to broader security-related spending to meet U.S. President Donald Trump's demand for a 5% target. REUTERS Join ST's Telegram channel and get the latest breaking news delivered to you.
Business Times
5 hours ago
- Business Times
Market Focus Daily: Monday, June 9, 2025
Asian markets rally ahead of latest China-US trade talks; Japan confirms GDP contraction, backing Bank of Japan's cautious stance; CapitaLand Investment expands fund with Japan asset acquisition at 30 billion yen. Synopsis: Market Focus Daily is a closing bell roundup by The Business Times that looks at the day's market movements and news from Singapore and the region. Written and hosted by: Emily Liu (emilyliu@ Produced and edited by: Chai Pei Chieh & Claressa Monteiro Produced by: BT Podcasts, The Business Times, SPH Media --- BT in your inbox Start and end each day with the latest news stories and analyses delivered straight to your inbox. Sign Up Sign Up Follow BT Market Focus and rate us on: Channel: Amazon: Apple Podcasts: Spotify: YouTube Music: Website: Feedback to: btpodcasts@ Do note: This podcast is meant to provide general information only. SPH Media accepts no liability for loss arising from any reliance on the podcast or use of third party's products and services. Please consult professional advisors for independent advice. Discover more BT podcast series: BT Money Hacks at: BT Correspondents: BT Podcasts: BT Branded Podcasts: BT Lens On: